Key Feature Of Self-Destructive Brain Disorder Revealed

May 28, 1996

"Patients with this disorder often spend most of their lives in restraints to prevent them from injuring themselves."

Researchers at Johns Hopkins, using high-tech medical imaging techniques, have found the suspected fingerprint of a devastating disorder that afflicts patients with uncontrollable urges to hurt themselves.

Hopkins scientists showed that brains of patients with the disorder, Lesch-Nyhan disease, may have much fewer nerve endings containing dopamine, an important chemical messenger.

The finding is an important step in developing future treatments, the researchers say. Newly developed drugs to treat other dopamine-related disorders already exist and may be useful for Lesch-Nyhan patients.

The study also may help researchers better understand the biological causes of a major behavioral problem of the severely mentally retarded.

"Many of the severely mentally retarded injure themselves," says Dean F. Wong, M.D., Ph.D., a Hopkins professor of radiology and lead author of the new study. "We're hoping that research into this rare disease may give us insights into the larger self-injurious population."

Lesch-Nyhan was first characterized at Johns Hopkins in the 1960s, when Hopkins physicians saw two brothers whose symptoms included mental retardation and self-biting--uncontrollable urges to bite their lips, fingers, tongue, arms and shoulders.

"Patients with this disorder often spend most of their lives in restraints to prevent them from injuring themselves," says James Harris, M.D., an author on the new study and director of the Hopkins Developmental Neuropsychiatry Program.

"The majority of these patients are very much aware of their predicament--the first patient I saw asked if his hands could be amputated to prevent himself from self-injury. Like many of these patients, his teeth had already been removed to prevent self-biting."

Lesch-Nyhan afflicts 1 in every 400,000 children, almost always occurring in males. Patients usually test in the mild to moderately retarded intelligence range, but some have normal intelligence levels.

In 1979, researchers at other institutions found the gene for Lesch-Nyhan on the X chromosome. Autopsies of three patients at another institution later suggested that the brains of Lesch-Nyhan patients might have unusually low levels of dopamine.

Hopkins investigators, working in conjunction with researchers at the University of North Carolina-Chapel Hill and the Montreal Neurological Institute, used positron emission tomography or PET to study brain levels of a dopamine transporter in normal adults and Lesch-Nyhan patients. The transporter recycles dopamine, removing it from its area of activity and preparing it for reuse. The Lesch-Nyhan patients had, on average, 75 percent less of the dopamine transporters in an area of the brain involved in controlling movement. This suggests they also have less dopamine in this area of the brain.

Researchers believe this dopamine reduction in Lesch-Nyhan patients changes the growth of nerve cell branches in the developing brain, mis-wiring an important area of the brain.

Drugs that affect the development of the dopamine system in early life may one day be used to ease or prevent the symptoms of Lesch-Nyhan, according to Wong.

"What still isn't clear, though, is how the Lesch-Nyhan mutation reduces dopamine levels," Harris notes. "The mutation alters an enzyme that is involved in the body's use of uric acid, causing kidney stones. We aren't sure how that metabolic alteration is linked to a reduction in dopamine levels."

To help solve this mystery, Harris is working with other researchers at Hopkins and North Carolina who have animal models of Lesch-Nyhan. In collaboration with researchers at Albert Einstein University, Harris is also looking for clues in the three-dimensional shape of the mutated Lesch-Nyhan protein.

This study was funded by a grant from the National Institute for Child Health and Development and support from the Mental Retardation Research Center, a joint Hopkins/Kennedy Krieger Institute project supported by the National Institutes of Health.

The findings are published in the May 28 issue of the Proceedings of the National Academy of Sciences. Other authors on the study were Sakkubai Naidu, Fuji Yokoi, Stefano Marenco, Robert Dannals, Hayden Ravert, Myron Yaster, Alan Evans, Olivier Rousset, R. Nick Bryan, Albert Gjedde, Michael Kuhar, and George Breese.

Johns Hopkins Medicine

Related Dopamine Articles from Brightsurf:

Dopamine surge reveals how even for mice, 'there's no place like home'
''There's no place like home,'' has its roots deep in the brain.

New dopamine sensors could help unlock the mysteries of brain chemistry
In 2018, Tian Lab at UC Davis Health developed dLight1, a single fluorescent protein-based biosensor.

Highly sensitive dopamine detector uses 2D materials
A supersensitive dopamine detector can help in the early diagnosis of several disorders that result in too much or too little dopamine, according to a group led by Penn State and including Rensselaer Polytechnic Institute and universities in China and Japan.

Dopamine neurons mull over your options
Researchers at the University of Tsukuba have found that dopamine neurons in the brain can represent the decision-making process when making economic choices.

Viewing dopamine receptors in their native habitat
A new study led by UT Southwestern researchers reveals the structure of the active form of one type of dopamine receptor, known as D2, embedded in a phospholipid membrane.

Significant differences exist among neurons expressing dopamine receptors
An international collaboration, which included the involvement of the research team from the Institut de Neurociències of the UAB (INC-UAB), has shown that neurons expressing dopamine D2 receptors have different molecular features and functions, depending on their anatomical localization within the striatum.

How dopamine drives brain activity
Using a specialized magnetic resonance imaging (MRI) sensor that can track dopamine levels, MIT neuroscientists have discovered how dopamine released deep within the brain influences distant brain regions.

Novelty speeds up learning thanks to dopamine activation
Brain scientists led by Sebastian Haesler (NERF, empowered by IMEC, KU Leuven and VIB) have identified a causal mechanism of how novel stimuli promote learning.

Evidence in mice that childhood asthma is influenced by the neurotransmitter dopamine
Neurons that produce the neurotransmitter dopamine communicate with T cells to enhance allergic inflammation in the lungs of young mice but not older mice, researchers report Nov.

Chronic adversity dampens dopamine production
People exposed to a lifetime of psychosocial adversity may have an impaired ability to produce the dopamine levels needed for coping with acutely stressful situations.

Read More: Dopamine News and Dopamine Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to